Andrew B Adams

Quick facts

Phase 3 pipeline

• Calcineurin inhibitor therapy · Immunology
  Calcineurin inhibitors suppress T-cell activation by blocking the phosphatase calcineurin, preventing the dephosphorylation and nuclear translocation of NFAT transcription factors required for cytokine production.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Andrew B Adams portfolio CI brief
• Andrew B Adams pipeline updates RSS